GLUE
Price
$24.12
Change
+$0.06 (+0.25%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.83B
56 days until earnings call
Intraday BUY SELL Signals
VTYX
Price
$13.87
Change
+$0.01 (+0.07%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
995.17M
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs VTYX

Header iconGLUE vs VTYX Comparison
Open Charts GLUE vs VTYXBanner chart's image
Monte Rosa Therapeutics
Price$24.12
Change+$0.06 (+0.25%)
Volume$41.52K
Capitalization1.83B
Ventyx Biosciences
Price$13.87
Change+$0.01 (+0.07%)
Volume$8.4K
Capitalization995.17M
GLUE vs VTYX Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. VTYX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (GLUE: $24.06 vs. VTYX: $13.86)
Brand notoriety: GLUE and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 71% vs. VTYX: 68%
Market capitalization -- GLUE: $1.83B vs. VTYX: $995.17M
GLUE [@Biotechnology] is valued at $1.83B. VTYX’s [@Biotechnology] market capitalization is $995.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLUE and VTYX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • GLUE’s TA Score: 5 bullish, 4 bearish.
  • VTYX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both GLUE and VTYX are a good buy in the short-term.

Price Growth

GLUE (@Biotechnology) experienced а +3.35% price change this week, while VTYX (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.83B) has a higher market cap than VTYX($995M). VTYX (53.488) and GLUE (53.444) have similar YTD gains . GLUE has higher annual earnings (EBITDA): 16.8M vs. VTYX (-115.4M). GLUE has more cash in the bank: 391M vs. VTYX (193M). VTYX has less debt than GLUE: VTYX (10M) vs GLUE (40.2M). GLUE has higher revenues than VTYX: GLUE (182M) vs VTYX (0).
GLUEVTYXGLUE / VTYX
Capitalization1.83B995M184%
EBITDA16.8M-115.4M-15%
Gain YTD53.44453.488100%
P/E Ratio75.16N/A-
Revenue182M0-
Total Cash391M193M203%
Total Debt40.2M10M402%
TECHNICAL ANALYSIS
Technical Analysis
GLUEVTYX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCLVX20.140.06
+0.30%
Optimum Large Cap Value C
QIORX16.940.01
+0.06%
AQR International Momentum Style R6
BGALX16.65N/A
N/A
Baillie Gifford Global Alpha Equities 4
ICHKX16.95-0.01
-0.06%
Guinness Atkinson China & Hong Kong
NLSAX19.69-0.10
-0.51%
Neuberger Berman Long Short A

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RVMD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
+0.29%
RVMD - GLUE
46%
Loosely correlated
+1.06%
KURA - GLUE
43%
Loosely correlated
+1.63%
CRNX - GLUE
41%
Loosely correlated
+2.04%
IMNM - GLUE
41%
Loosely correlated
+3.08%
CCCC - GLUE
40%
Loosely correlated
+0.87%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with NMRA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then NMRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
N/A
NMRA - VTYX
41%
Loosely correlated
+0.47%
KYMR - VTYX
40%
Loosely correlated
+1.46%
GLUE - VTYX
39%
Loosely correlated
+0.29%
NAMS - VTYX
39%
Loosely correlated
+0.19%
REPL - VTYX
38%
Loosely correlated
-4.10%
More